Floatz logo

4-OXYPIPERIDOL

Biochemical Recurrent Prostate Cancer

Matrix Biomed, Inc.Small moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Biochemical Recurrent Prostate Cancer cohort.

Asset / SponsorPhaseRating

Same molecule, other indications

4-OXYPIPERIDOL is also rated in:

glioblastomaDormant
CCC
Indicative ·
48 / 100
View asset →
Cardiovascular Risk FactorDormant
CC
Indicative ·
47 / 100
View asset →
VasodilationDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →